StocksMedium•8 October 2026•
1 min read
Clover Health Medicare Advantage Plans Earn 5-Star Rating for 2027
Key Facts
1Clover Health's PPO Medicare Advantage plans received a 5-star rating from CMS for 2027, while its HMO plan received 4.5 stars.
Clover Health's PPO Medicare Advantage plans received a 5-star rating from the Centers for Medicare & Medicaid Services (CMS) for 2027. Reuters reported that the company's HMO plan also earned a 4.5-star rating as part of the annual quality assessment.
CLOV closed at $4.56 on October 7, 2026, after reaching a day high of $4.75 and a low of $4.53. These highest-possible ratings are expected to influence future reimbursement rates and enrollment attractiveness, specifically impacting payments for the 2028 fiscal year.